StockClub

HTSUY

HTSUYHisamitsu Pharmaceutical Co., Inc.$ --
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUY

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 11/30/2025FY2025 Q3
Revenue
262M USD
YoY +8.8%
Operating Income
30M USD
YoY +4.7%
Net Income
32M USD
YoY +5.0%
EPS
0.11$
YoY 0.0%

Revenue

$774.4M
FY2023 Q4$988.7M
$988.7M
Q4
FY2024 Q1$233.5M
$233.5M
Q1
FY2024 Q2$491M
$491M
Q2
FY2024 Q3$731.6M
$731.6M
Q3
FY2024 Q4$1B
$1B
Q4
FY2025 Q1$237.5M
$237.5M
Q1
FY2025 Q2$512.7M
$512.7M
Q2
FY2025 Q3$774.4M
$774.4M
Q3
Actual
+$42.8M (+5.9%)

Net Income

$80.2M
FY2023 Q4$98.2M
$98.2M
Q4
FY2024 Q1$31.2M
$31.2M
Q1
FY2024 Q2$59.2M
$59.2M
Q2
FY2024 Q3$89.9M
$89.9M
Q3
FY2024 Q4$142.5M
$142.5M
Q4
FY2025 Q1$17.6M
$17.6M
Q1
FY2025 Q2$48M
$48M
Q2
FY2025 Q3$80.2M
$80.2M
Q3
Actual
$-9.6M (-10.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$1.3B
FY2019
$1.3B
FY2020
Actual:$1.1B
FY2020
$1.1B
FY2021
Actual:$1.1B
FY2021
$1.1B
FY2022
Actual:$957M
FY2022
$957M
FY2023
Actual:$989.3M
FY2023
$989.3M
FY2024
Actual:$1B
FY2024
$1B

Analyst Estimates

No forecast data